We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
2023-2028 Monoclonal Antibodies Outlook for Japan - mAbs Market
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 37 days · 37 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 37 days • 1 price levels
Price Analysis
Most common price: £495 (37 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 37 days
Description
Key Features
Latent demand forecasts for monoclonal antibodies across Japanese prefectures and over 1,000 cities through 2028.
Potential industry earnings (P.I.E.) estimates provided in millions of U.S. dollars for regional market assessment.
Comparative benchmarking showing each city's percentage share of its prefecture and Japan's total mAbs market.
Econometric models project fundamental demand drivers to support distribution and sales force strategy development.
Published by ICON Group International, Inc., a recognised authority on market analysis and industry forecasting.
Product Specifications
- Format
- paperback
- ASIN
- B0BP9S1JQ7
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 28 November 2022
- Listed Since
- 08 December 2022
Similar Products You Might Like
The 2023-2028 Outlook for Monoclonal Antibodies Market in Breast Cancers in India
2023-2028 Cognitive Memory Enhancer Drugs Outlook Japan
The 2023-2028 Outlook for Genital Herpes Treatments in Japan
2023-2028 Artificial Tears Market Outlook Japan - Cities & Prefectures
The 2023-2028 Outlook for Orphan Biologic Drugs in India
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
The 2023-2028 Outlook for Allergic Rhinitis in Japan
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States
The 2023-2028 Outlook for Immune-Oncology Treatments in India
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in the United States
The 2023-2028 Outlook for Rheumatology Therapeutics in India
The 2023-2028 Outlook for Hepatitis Drugs in the United States
The 2023-2028 Outlook for Biologic Vasculitis Treatments in India
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
The 2023-2028 Outlook for Vasculitis Treatments in India
The 2023-2028 Outlook for Blood Products in India
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in India
The 2023-2028 Outlook for Thyroid Gland Disorders in India
The 2023-2028 Outlook for Myasthenia Gravis Treatments in India
The 2023-2028 Outlook for Neurology in the United States